Literature DB >> 6659963

Pharmacokinetics of the gamma-aminobutyric acid agonist THIP (Gaboxadol) following intramuscular administration to man, with observations in dog.

S M Madsen, T Lindeburg, S Følsgård, E Jacobsen, H Sillesen.   

Abstract

The pharmacokinetics of the gamma-aminobutyric acid (GABA) agonist, THIP (Gaboxadol) has been studied following intramuscular administration of 10 or 20 mg THIP-monohydrate to six healthy human volunteers. Additional experiments with special reference to the possible occurrence of non-linear kinetics and to estimation of the efficiency of absorption were carried out in three beagle dogs. As estimated from the dogs, absorption of THIP from the site of injection was efficient (F = 0.94 +/- 0.16, mean +/- S.D., in 8 experiments). The time course of the THIP serum concentration was in all experiments adequately described by an open 1-compartment linear model. In most individual experiments a near maximum concentration was present at 15 or 10 min. after the administration to man and dog, respectively. In some subjects and dogs an uncertain relation was found between dose and the time integral of the THIP serum concentration, but the mode of variation did not suggest deviations from first-order kinetics at high doses or concentrations. The rate constant of elimination was estimated to 0.50 +/- 0.13 hr-1 and 0.52 +/- 0.13 hr-1 following injection of a 10 or 20 mg dose, respectively, to man (mean +/- S.D., n = 6), and similar values were obtained from the dogs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6659963     DOI: 10.1111/j.1600-0773.1983.tb03434.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

1.  Contributions of the hippocampus and entorhinal cortex to rapid visuomotor learning in rhesus monkeys.

Authors:  Tianming Yang; Rachel L Bavley; Kevin Fomalont; Kevin J Blomstrom; Andrew R Mitz; Janita Turchi; Peter H Rudebeck; Elisabeth A Murray
Journal:  Hippocampus       Date:  2014-05-06       Impact factor: 3.899

2.  Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia.

Authors:  Trine Damgaard; Niels Plath; Jo C Neill; Suzanne L Hansen
Journal:  Psychopharmacology (Berl)       Date:  2010-10-19       Impact factor: 4.530

3.  Characterization of GABA(A) receptor ligands in the rat cortical wedge preparation: evidence for action at extrasynaptic receptors?

Authors:  B Ebert; S i Storustovu; M Mortensen; B Frølund
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

4.  Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics.

Authors:  Delia Belelli; Dianne R Peden; Thomas W Rosahl; Keith A Wafford; Jeremy J Lambert
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

5.  Acutely increasing δGABA(A) receptor activity impairs memory and inhibits synaptic plasticity in the hippocampus.

Authors:  Paul D Whissell; Dave Eng; Irene Lecker; Loren J Martin; Dian-Shi Wang; Beverley A Orser
Journal:  Front Neural Circuits       Date:  2013-09-17       Impact factor: 3.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.